Mesirow Financial Investment Management - Fixed Income’s Gilead Sciences GILD Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,083	Closed	-$365K	–	199
2016 Q4	$365K	Hold	5,083	–	–	0.02%	183
2016 Q3	$402K	Sell	5,083 -2,850	-36%	-$232K	0.02%	174
2016 Q2	$662K	Sell	7,933 -6,584	-45%	-$584K	0.04%	148
2016 Q1	$1.33M	Hold	14,517	–	–	0.61%	77
2015 Q4	$1.47M	Sell	14,517 -30	-0.2%	-$3.12K	0.68%	65
2015 Q3	$1.43M	Sell	14,547 -57	-0.4%	-$6.33K	0.4%	89
2015 Q2	$1.71M	Sell	14,604 -160	-1%	-$17.5K	0.41%	89
2015 Q1	$1.45M	Buy	14,764 +6,749	+84%	+$685K	0.35%	100
2014 Q4	$755K	Buy	+8,015	New	+$829K	0.19%	136

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's GILD Position: Q1 2017 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 5,083 shares — an estimated $365K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in GILD in Q4 2014 and held it in 9 quarters. The position peaked at $1.71M in Q2 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Mesirow Financial Investment Management - Fixed Income reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 5,083 Gilead Sciences shares in Q1 2017, an estimated $365K.
Mesirow Financial Investment Management - Fixed Income first reported a position in Gilead Sciences in Q4 2014 and held it in 9 quarters.
Mesirow Financial Investment Management - Fixed Income's Gilead Sciences position peaked at $1.71M in Q2 2015.
1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q1 2017, filed 25 Apr 2017.